The immunological mechanisms leading to Graves' disease are not yet fully understood. The athymic nude mouse has immunological properties which allow in vivo studies concerning autoimmune thyroid diseases with special regard to the interaction of TSH, TSH receptor antibodies, cytokines, antithyroid drugs, TSH receptor antagonists and human lymphocytes. In our own studies thyroid tissues of patients with Graves' disease, toxic adenomas and non-toxic nodular goiter were xenotransplanted to athymic nude mice. Histology, morphology and function of the transplants were examined 2 days to 2 weeks after injection of bovine TSH, interferon-gamma, Graves' sera with or without addition of a TSH-receptor antagonist and lymphocytes of patients with Graves' disease. Thyroid transplants can be stimulated by TSH, interferon-gamma, Graves' sera and immunoglobulin G. Additional treatment with asialoagalacto-hCG inhibits stimulation of the immunoglobulin. Furthermore, preliminary results show, that engrafted peripheral and especially intrathyroidal lymphocytes from patients with Graves' disease specifically migrate into human thyroid transplants ("homing") and are able to induce functional and histological changes in these tissues. In summary, the xenotransplantation model is well suited for studies concerning pathogenesis, diagnosis and therapy of autoimmune thyroid diseases.
Introduction
As the ongoing discussion concerning the pathogenesis of human thyroid autoimmune disease demonstrates there are still a lot of open questions to be answered with respect to pathogenesis, pathophysiology, diagnosis and therapy in particular involved in hyperthyroidism of Graves' disease. The role of TSH receptor autoantibodies inducing/blocking thyroid function and/or growth in autoimmune thyroid disease (AITD), the effects of TSH receptor antagonists, the special function of intrathyroidal lymphocytes, the expression of MHC class II antigens and adhesion molecules has to be investigated with special regard to development and time-course of AITD and relation to other immunological phenomena important for the initiation and augmentation of AITD.
It is obvious that studies of human AITD requiring manipulations of the immune environment cannot be carried out directly in patients. However, in contrast to in vitro studies using thyroid and immune cells of human origin, there are many advantages to the study of human thyroid tissue in in vivo conditions and the availibility of the athymic nude mouse make this possible.
As previous studies by several groups including our own have shown [1] [2] [3] [4] [5] [6] [7] [8] [9] it is possible to xenotransplant human thyroid tissue from patients with various thyroid diseases and to study the pathophysiology as well as the effects of therapeutic measures under in vivo conditions, the xenotransplantation model seems to be well suited to investigate factors originating from the patients immune system which may be important for the initiation of thyroiddirected autoimmune processes.
In the presented experimental studies the following items will be addressed:
1. In vivo effects of TSH receptor antibodies on function, growth, morphology and immunological phenomena of human thyroid transplants in comparison to effects of bovine TSH, cytokines and antithyroid drug therapy. 2. In vivo effects of TSH receptor antagonists on functional and immunological responses of thyroid transplants. 3. In vivo effects of peripheral and intrathyroidal lymphocytes derived from patients with Graves' disease (GD) or non-toxic nodular goiter (NTG) on function, growth, morphology and immunological phenomena of thyroid transplants.
TSH receptor antibodies -in vivo stimulation of thyroid function
In order to investigate the in vivo effects of TSH receptor autoantibodies stimulating thyroid function human thyroid tissue derived from patients with GD or toxic adenoma was transplanted to athymic nude mice [4, 10] . Sera and preparations of immunoglobulin fractions respectively were obtained from patients with thyrotoxicosis due to active untreated GD. Histological and morphological examination of the thyroid transplants and mouse thyroids included determination of cell nucleus volume. To define thyroid function, iodine kinetics (131 I-retention of the whole animal, thyroid transplant, mouse thyroid) were determined and in addition 131 iodine autoradiographies of thyroid transplants were carried out. Furthermore, the 131 iodine bound thyroxine was measured in the animals [10] [11] [12] [13] . Thyroid histology, morphology and function were examined before and 4 days to 2 weeks after injections of sera or immunoglobulin fractions from patients with GD into athymic nude mice.
In a second experiment thyroid tissue of GD, transplanted to athymic nude mice was exposed to injections of sera obtained from patients with either untreated active GD with or without goiter, GD in remission or non-toxic sporadic goiter. In addition to the above described methods the follicle count and 3 H-thymidine incorporation in the thyroid transplants were determined.
As hyperfunction of thyroid tissue of GD depends upon extrinsic stimulators, it loses all signs of hyperfunction, in contrast to transplants of toxic adenomas, 8 weeks after transplantation [2, 3] . In addition, the characteristic lymphocytic infiltration of thyroid tissue of GD cannot be identified in the transplants 8 weeks after transplantation and the thyrocytes quickly lose their HLA-DR expression which had been manifested in vivo in the human disease [8, 14] . The reason for this normalization is that lymphocytes in the xenografts are lysed by the animal. These transplants, however, can again be stimulated by injection of sera or immunoglobulin fractions of patients with active GD containing thyroid stimulating TSH receptor antibodies. Nuclear volume of thyroid follicular cells, a very sensitive parameter of endocrine function [15] , significantly increases after inlections of thyroid stimulating TSH receptor antibodies. All parameters of thyroid function, including 131 iodine retention and autoradiography of thyroid transplants as well as 131 iodine bound thyroxine, which were determined additionally, confirmed a significant increase of function in thyroid transplants [3, 11, 12] . The increase of thyroid transplants functions see.ms to be even more pronounced after injection of homologous in contrast to autologous sera of patients with GD [13] .
In summary the results of the second part of the study demonstrate that thyroid function and growth are independent phenomena which can be differentiated experimentally by means of the xenotransplantation model. By the use of the xenotransplantation model thyroidal autonomy and GD can clearly be distinguished. Morphological and functional data of the examination of the mouse thyroids are contradictory and do not allow a characterization of TSH receptor antibodies [3] . An increase of thyroid function, similar to the effects of TSH receptor antibodies can be achieved after injections of bovine TSH [3] . In addition, experimental studies to evaluate the effects of thyroid function stimulators and iodine excess on thyroid transplants of GD and toxic adenomas clearly show that thyroid hyperfunction in stimulated Graves' transplants is mainly regulated by the presence of TSH receptors antibodies and not by iodine excess, in contrast to transplanted toxic adenomas [11, 12] .
In extension of previous, above summarized results showing that the function of human thyroid transplants of GD tissues can be stimulated by TSH receptor antibodies from patients with GD without influencing growth parameters [2, 3] , the results of the second experiment show a separate as well simultaneous stimulation of function and/or growth by sera from different patients who had developed the respective clinical manifestations. TSH seems to play a minor role in the regulation of thyroid growth [13] .
Different TSH receptor stimulators -expression of products of the immunoglobulin supergene family
We examined the in vivo effects of TSH receptor antibodies, TSH, cytokines, growth factors and antithyroid drugs on xenotransplanted human thyroid tissue from patients with GD. In addition to the above described methods thyroid transplants were examined immuno-histochemically to determine the expression of MHC class II and various adhesion molecules of thyroid cells.
Immunohistochemical examination of thyroid transplants revealed that immunoglobulin fractions containing stimulating TSH receptor antibodies from patients with GD are able to alter the expression of gene products (MHC class II; adhesion molecules: ICAM-1) in human thyroid transplants in vivo. Similar effects can be found in thyroid transplants after treatment with interferon-gamma and are most augmented when TSH is given additionally. The immunohistochemical findings are slightly reduced by interleukin-2, high doses of growth factors or the antithyroid drug methimazole [16] .
We investigated whether the inappropriate expression of various products of the immunoglobulin supergene family plays a role in the initiation and/or perpetuation of AITD. The data show that TSH-receptor antibodies are able to alter the expression of gene production in human thyroid transplants of GD, similar to the effect of cytokines.
TSH receptor antagonists -in vivo inhibition of functional and immunological responses to thyroid stimulating antibodies
We investigated the effects of a TSH receptor blockade with asialoagalacto-hCG on functional and immunological responses to thyroid stimulation by Graves' immunoglobulines in the xenotransplantation model.
After injection of purified Graves' immunoglobulins G thyroid hormone production, cellular hypertrophy of transplants thyrocytes, expression of HLA-DR antigens by transplant thyroid follicular cells, and expression of adhesion molecules (ICAM-1) were significantly increased in a dose dependent manner. Additional treatment of the animals with the TSH receptor antagonist asialoagalacto-hCG
